Lexaria Announces New R&D Plans for 2026

Core Insights - Lexaria Bioscience Corp. has initiated its 2026 research and development program aimed at expanding pharmaceutical, intellectual property, and business development opportunities through new and improved formulations [1] Group 1 - The 2026 R&D Program will focus on three new studies that represent the company's primary areas of focus for at least the first three quarters of the calendar year [1] - The announced studies are part of a broader strategy to enhance business opportunities within the pharmaceutical sector [1]